| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
syntaxin 1A | 0.621 | 0.654 | 0.98 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2017 | ||||||||
|
SET domain containing 1A, histone lysine methyltransferase | 0.619 | 0.615 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2017 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
sulfatase modifying factor 2 | 0.623 | 0.769 | 1.0E-08 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2015 | ||||||||
|
syntaxin 2 | 0.626 | 0.577 | 2.1E-07 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2017 | ||||||||
|
cathelicidin antimicrobial peptide | 0.466 | 0.846 | 4.4E-03 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2017 | ||||||||
|
vinculin | 0.575 | 0.654 | 4.7E-02 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.674 | 0.538 | 5.8E-02 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2013 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
surfactant protein A1 | 0.546 | 0.808 | 3.7E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
translocator protein | 0.444 | 0.885 | 2.7E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
mitochondrial E3 ubiquitin protein ligase 1 | 0.473 | 0.808 | 1.9E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 2 | 0.513 | 0.885 | 3.6E-07 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2017 | ||||||||
|
ubiquitin conjugating enzyme E2 N | 0.593 | 0.654 | 0.88 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
lysozyme | 0.526 | 0.846 | 3.4E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
ezrin | 0.476 | 0.808 | 0.18 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2000 | ||||||||
|
epithelial membrane protein 1 | 0.560 | 0.769 | 0.50 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1989 | 2015 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1987 | 1990 | ||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | |||||||||
|
WASP like actin nucleation promoting factor | 0.678 | 0.500 | 0.88 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2017 | ||||||||
|
unconventional SNARE in the ER 1 | 0.592 | 0.769 | 2.1E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1996 | 2013 | ||||||||
|
nucleotide binding oligomerization domain containing 1 | 0.541 | 0.769 | 2.5E-18 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2017 | ||||||||
|
defensin alpha 5 | 0.695 | 0.423 | 5.2E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 |